Assessing Diagnostics At Point-of-care for Tuberculosis

Recruiting now · Not applicable

Conditions studied: Tuberculosis

In brief

Every year, more than 3 million people with TB remain undiagnosed and 1 million die. Better diagnostics are essential to reducing the enormous burden of TB worldwide. The Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT) study seeks to reduce the burden of TB worldwide by evaluating faster, simpler, and less expensive TB triage and diagnostic tests.

Key facts

Study ID

NCT05941052

Run by

University of California, San Francisco

People needed

1350

Starts

2023-08-28

Expected to finish

2028-09-30

Last updated by the study team

2026-03-09

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Zankli Research Center, Bingham University — Abuja, Nigeria (enrolling)
• De La Salle Medical and Health Sciences Institute — Dasmariñas, Philippines (enrolling)
• Centre for Infectious Disease Research in Zambia — Lusaka, Zambia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.